In vitro derivation of functional insulin-producing cells from human embryonic stem cells  被引量:38

In vitro derivation of functional insulin-producing cells from human embryonic stem cells

在线阅读下载全文

作  者:Wei Jiang Yan Shi Dongxin Zhao Song Chen Jun Yong Jing Zhang Tingting Qing Xiaoning Sun Peng Zhang Mingxiao Ding Dongsheng Li Hongkui Deng 

机构地区:[1]Department of Cell Biology and Genetics, College of Life Sciences, Peking University, Beijing 100871, China [2]Beijing Laboratory Animals Research Center, Beijing 100012, China [3]Laboratory of Chemical Genomics, Shenzhen Graduate School of Peking University, the University Town, Shenzhen 518055, China [4]provincial Key Laboratory of Embryonic Stem Cell Research, Tai-He Hospital Yunyang Medical College, 32 S. Renmin Rd., Shiyan 442000, China

出  处:《Cell Research》2007年第4期333-344,共12页细胞研究(英文版)

基  金:This research was supported by the Ministry of Science and Technology Grant (2001CB510106);Science and Technology Plan of Beijing Municipal Government (H020220050290);National Natural Science Foundation of China Awards for 0utstanding Young Scientists (30125022);for Creative Research Groups (30421004);Bill & Melinda Gates Foundation Grant (37871) to H Deng.

摘  要:The capacity for self-renewal and differentiation of human embryonic stem (ES) cells makes them a potential source for generation of pancreatic beta cells for treating type I diabetes mellitus. Here, we report a newly developed and effective method, carried out in a serum-free system, which induced human ES cells to differentiate into insulin-producing cells. Activin A was used in the initial stage to induce definitive endoderm differentiation from human ES cells, as detected by the expression of the definitive endoderm markers Sox17 and Brachyury. Further, all-trans retinoic acid (RA) was used to promote pancreatic differentiation, as indicated by the expression of the early pancreatic transcription factors pdxl and hlxb9. After maturation in DMEM/F12 serum-free medium with bFGF and nicotinamide, the differentiated cells expressed islet specific markers such as C-peptide, insulin, glucagon and glut2. The percentage of C-peptide-positive cells exceeded 15%. The secretion of insulin and C-peptide by these cells corresponded to the variations in glucose levels. When transplanted into renal capsules of Streptozotocin (STZ)-treated nude mice, these differentiated human ES cells survived and maintained the expression of beta cell marker genes, including C-peptide, pdxl, glucokinase, nkx6.1, lAPP, pax6 and Tcfl. Thirty percent of the transplanted nude mice exhibited apparent restoration of stable euglycemia; and the corrected phenotype was sustained for more than six weeks. Our new method provides a promising in vitro differentiation model for studying the mechanisms of human pancreas development and illustrates the potential of using human ES cells for the treatment of type I diabetes mellitus.

关 键 词:human embryonic stem cell direct differentiation insulin-producing cell DIABETES 

分 类 号:R335.6[医药卫生—人体生理学] R587.1[医药卫生—基础医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象